Levoflox: Advanced Broad-Spectrum Antibiotic Therapy
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.99 | $59.34 (0%) | 🛒 Add to cart |
| 90 | $0.91 | $89.01 $81.70 (8%) | 🛒 Add to cart |
| 120 | $0.82 | $118.68 $98.90 (17%) | 🛒 Add to cart |
| 180 | $0.75 | $178.02 $135.02 (24%) | 🛒 Add to cart |
| 270 | $0.71 | $267.03 $191.78 (28%) | 🛒 Add to cart |
| 360 | $0.67
Best per pill | $356.04 $240.80 (32%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.32 | $39.56 (0%) | 🛒 Add to cart |
| 60 | $1.16 | $79.12 $69.66 (12%) | 🛒 Add to cart |
| 90 | $1.09 | $118.68 $98.04 (17%) | 🛒 Add to cart |
| 120 | $1.02 | $158.24 $122.12 (23%) | 🛒 Add to cart |
| 180 | $0.95 | $237.36 $170.28 (28%) | 🛒 Add to cart |
| 270 | $0.91 | $356.04 $245.10 (31%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $474.72 $315.62 (34%) | 🛒 Add to cart |
| Product dosage: 700mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.38 | $41.28 (0%) | 🛒 Add to cart |
| 60 | $1.33 | $82.56 $79.98 (3%) | 🛒 Add to cart |
| 90 | $1.27 | $123.84 $114.38 (8%) | 🛒 Add to cart |
| 120 | $1.20 | $165.12 $144.48 (13%) | 🛒 Add to cart |
| 180 | $1.15 | $247.68 $206.40 (17%) | 🛒 Add to cart |
| 270 | $1.10 | $371.52 $295.84 (20%) | 🛒 Add to cart |
| 360 | $1.06
Best per pill | $495.36 $382.70 (23%) | 🛒 Add to cart |
Synonyms | |||
Levoflox is a potent fluoroquinolone antibiotic indicated for the treatment of adults with serious bacterial infections. It demonstrates excellent tissue penetration and bactericidal activity against a wide range of Gram-positive and Gram-negative pathogens, including some multidrug-resistant strains. Its once-daily dosing regimen supports patient compliance, while its well-established pharmacokinetic profile ensures predictable and effective therapeutic outcomes across multiple infection sites.
Features
- Active ingredient: Levofloxacin (as hemihydrate)
- Available in 250 mg, 500 mg, and 750 mg film-coated tablets
- Also available as intravenous solution for hospital use
- Rapid and nearly complete oral bioavailability (~99%)
- Extended half-life (~7–8 hours) allowing for once-daily dosing
- Broad spectrum of activity covering both typical and atypical pathogens
Benefits
- Effectively treats severe and complicated bacterial infections when first-line agents fail
- High tissue penetration ensures therapeutic concentrations at common infection sites including lungs, skin, and urinary tract
- Convenient once-daily oral dosing improves adherence compared to multiple-dose regimens
- Demonstrated efficacy against many antibiotic-resistant strains including some MRSA and Pseudomonas aeruginosa isolates
- Suitable for sequential therapy (IV to oral switch) to facilitate early discharge and outpatient management
- Well-documented clinical success in both community-acquired and healthcare-associated infections
Common use
Levoflox is indicated for the treatment of adults with:
- Community-acquired pneumonia (including multidrug-resistant Streptococcus pneumoniae)
- Complicated urinary tract infections, including pyelonephritis
- Acute bacterial exacerbation of chronic bronchitis
- Complicated skin and skin structure infections
- Acute bacterial sinusitis
- Chronic bacterial prostatitis
- Inhalational anthrax (post-exposure)
It should be reserved for infections proven or strongly suspected to be caused by susceptible bacteria, particularly when alternative treatment options are limited, ineffective, or contraindicated.
Dosage and direction
Dosage should be adjusted based on infection type, severity, renal function, and pathogen susceptibility:
Oral Administration (tablets):
- Community-acquired pneumonia: 500 mg once daily for 7–14 days
- Complicated UTI/pyelonephritis: 250 mg once daily for 10 days
- Complicated skin infections: 750 mg once daily for 7–14 days
- Chronic bacterial prostatitis: 500 mg once daily for 28 days
Intravenous Administration:
- Equivalent doses administered by IV infusion over 60–90 minutes
- Switch to oral therapy at same dose when clinically appropriate
Renal Impairment Adjustment:
- CrCl 20–49 mL/min: extend dosing interval to every 48 hours
- CrCl 10–19 mL/min: initial dose of 750 mg followed by 500 mg every 48 hours
Tablets should be swallowed whole with water, with or without food, though administration 2 hours before or after antacids, sucralfate, or metal cations is recommended.
Precautions
- Tendon inflammation or rupture may occur during or after therapy, particularly in elderly patients, those with renal impairment, or solid organ transplant recipients
- Exacerbation of myasthenia gravis, including respiratory failure and death, has been reported
- Peripheral neuropathy may occur and can be irreversible
- CNS effects including seizures, increased intracranial pressure, and psychiatric reactions have been observed
- Photosensitivity/phototoxicity reactions may occur; patients should avoid excessive sunlight and artificial UV exposure
- Blood glucose disturbances, including both hypoglycemia and hyperglycemia, have been reported, particularly in diabetic patients
- Clostridium difficile-associated diarrhea may range from mild to life-threatening
Contraindications
- Known hypersensitivity to levofloxacin, other quinolones, or any component of the formulation
- History of tendon disorders related to fluoroquinolone administration
- Patients with myasthenia gravis (may exacerbate muscle weakness)
- Concurrent administration with tizanidine (contraindicated due to CYP1A2 inhibition)
- Pediatric patients (except for inhalational anthrax post-exposure)
- Pregnancy and breastfeeding (unless potential benefit justifies potential risk)
Possible side effect
Common (≥1%):
- Nausea (3–7%)
- Diarrhea (3–6%)
- Headache (3–6%)
- Constipation (2–4%)
- Dizziness (2–3%)
- Insomnia (2–3%)
Less common but serious:
- Tendinitis and tendon rupture (particularly Achilles tendon)
- Peripheral neuropathy
- CNS effects (seizures, anxiety, confusion, depression)
- QT interval prolongation and ventricular arrhythmias
- Hepatotoxicity (elevated transaminases, hepatitis)
- Blood disorders (leukopenia, thrombocytopenia)
- Severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis)
- Aortic aneurysm and dissection
Drug interaction
- Antacids, sucralfate, metal cations (iron, zinc, calcium, magnesium): Significantly reduce absorption; administer levofloxacin at least 2 hours before or 4 hours after these products
- Warfarin: Enhanced anticoagulant effect; monitor INR closely
- Oral hypoglycemics: May potentiate hypoglycemic effects
- NSAIDs: Increased risk of CNS stimulation and seizures
- Corticosteroids: Increased risk of tendon rupture
- QT-prolonging drugs (antiarrhythmics, antipsychotics, macrolides): Additive effect on QT interval; avoid combination when possible
- Theophylline: Increased theophylline levels; monitor concentrations
- Cyclosporine: Elevated serum creatinine; monitor renal function
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed dose. Maintaining consistent antibiotic levels is important for efficacy and resistance prevention.
Overdose
Symptoms may include CNS excitation (seizures, dizziness, tremor), gastrointestinal distress (nausea, vomiting), and renal impairment. ECG monitoring is recommended due to potential QT prolongation. Management is supportive with hydration and symptomatic treatment. Hemodialysis removes approximately 10% of the dose, but is not routinely recommended. There is no specific antidote.
Storage
- Store at 20–25°C (68–77°F); excursions permitted to 15–30°C (59–86°F)
- Protect from light and moisture
- Keep in original container with lid tightly closed
- Do not transfer tablets to other containers
- Keep out of reach of children and pets
- Do not use after expiration date printed on packaging
- IV solutions should be stored at controlled room temperature and protected from light
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Levoflox is a prescription medication that should only be used under the supervision of a qualified healthcare professional. The prescribing physician should review full prescribing information, including boxed warnings regarding tendonitis, tendon rupture, peripheral neuropathy, and CNS effects. Treatment decisions should be based on individual patient factors, susceptibility testing, and local resistance patterns. Always follow your healthcare provider’s instructions regarding dosage, duration, and monitoring.
Reviews
“Levoflox has been invaluable in our ICU for treating multidrug-resistant Gram-negative infections. The once-daily dosing simplifies our protocol and the IV-to-oral switch capability has significantly reduced length of stay for appropriate patients.” — Infectious Disease Specialist, 15 years experience
“In complicated UTIs with pseudomonal involvement, levoflox remains a reliable option when culture results confirm susceptibility. I appreciate the predictable pharmacokinetics and generally favorable safety profile in appropriately selected patients.” — Urologist, 12 years experience
“We reserve levoflox for cases where narrower-spectrum options have failed or are contraindicated. While effective, we carefully assess risk factors for tendonopathy and monitor patients closely throughout therapy.” — Internal Medicine Physician, 8 years experience
“The ability to achieve high tissue concentrations makes levoflox particularly effective in prostatic infections. The 28-day course for chronic bacterial prostatitis has shown excellent eradication rates in my practice.” — Urology Specialist, 10 years experience